Insider Transactions in Q3 2021 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 15
2021
|
Miriam Provost VP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
3,877
-31.19%
|
$120,187
$31.34 P/Share
|
Sep 15
2021
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,625
+31.15%
|
$90,000
$16.14 P/Share
|
Sep 07
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.64%
|
$350,000
$35.0 P/Share
|
Sep 07
2021
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.89%
|
$0
$0.67 P/Share
|
Sep 07
2021
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,941
-7.88%
|
$137,935
$35.08 P/Share
|
Sep 07
2021
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,941
+7.3%
|
$0
$0.28 P/Share
|
Sep 01
2021
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
1,680
-82.14%
|
$53,760
$32.07 P/Share
|
Sep 01
2021
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,680
+50.0%
|
$3,360
$2.21 P/Share
|
Aug 30
2021
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+18.31%
|
$0
$0.28 P/Share
|
Aug 02
2021
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
1,680
-100.0%
|
$47,040
$28.33 P/Share
|
Aug 02
2021
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,680
+50.0%
|
$3,360
$2.21 P/Share
|
Jul 30
2021
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,206
+24.48%
|
$6,618
$3.22 P/Share
|
Jul 15
2021
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,152
-10.06%
|
$180,320
$35.1 P/Share
|
Jul 15
2021
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,152
+9.14%
|
$0
$0.28 P/Share
|
Jul 15
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.64%
|
$350,000
$35.0 P/Share
|
Jul 15
2021
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.89%
|
$0
$0.67 P/Share
|
Jul 01
2021
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
1,680
-94.05%
|
$55,440
$33.82 P/Share
|
Jul 01
2021
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,680
+50.0%
|
$3,360
$2.21 P/Share
|